First Heartland Consultants’s AbbVie ABBV Stock Holding History

First Heartland Consultants’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948K	Buy	3,768 +197	+6%	+$42.4K	0.06%	227
2026 Q1	$777K	Sell	3,571 -2,265	-39%	-$502K	0.06%	218
2025 Q4	$1.33M	Buy	5,836 +48	+0.8%	+$10.9K	0.1%	153
2025 Q3	$1.34M	Sell	5,788 -9	-0.2%	-$1.83K	0.11%	147
2025 Q2	$1.08M	Buy	5,797 +727	+14%	+$135K	0.1%	160
2025 Q1	$1.06M	Sell	5,070 -276	-5%	-$53.7K	0.11%	143
2024 Q4	$950K	Buy	5,346 +4	+0.1%	+$735	0.1%	150
2024 Q3	$1.05M	Sell	5,342 -655	-11%	-$122K	0.11%	135
2024 Q2	$1.03K	Buy	5,997 +50	+0.8%	+$8.28K	0.07%	171
2024 Q1	$1.08M	Buy	5,947 +3	+0.1%	+$517	0.11%	157
2023 Q4	$921K	Sell	5,944 -3,148	-35%	-$459K	0.11%	149
2023 Q3	$1.35M	Buy	9,092 +1	+0%	+$147	0.17%	119
2023 Q2	$1.22M	Sell	9,091 -272	-3%	-$39.9K	0.16%	124
2023 Q1	$1.49M	Sell	9,363 -772	-8%	-$118K	0.22%	103
2022 Q4	$1.64M	Sell	10,135 -6,027	-37%	-$924K	0.26%	89
2022 Q3	$2.17K	Sell	16,162 -792	-5%	-$114K	0.19%	75
2022 Q2	$2.6M	Sell	16,954 -214	-1%	-$32.7K	0.41%	59
2022 Q1	$2.87M	Sell	17,168 -5,589	-25%	-$812K	0.45%	46
2021 Q4	$3.08K	Buy	22,757 +2,184	+11%	+$258K	0.12%	54
2021 Q3	$2.22M	Buy	20,573 +414	+2%	+$47.3K	0.34%	75
2021 Q2	$2.27M	Buy	20,159 +1,069	+6%	+$120K	0.34%	82
2021 Q1	$2.07M	Buy	19,090 +1,594	+9%	+$170K	0.33%	82
2020 Q4	$1.88M	Buy	17,496 +5,158	+42%	+$496K	0.31%	71
2020 Q3	$1.08M	Buy	12,338 +7,585	+160%	+$714K	0.2%	91
2020 Q2	$467K	Buy	4,753 +320	+7%	+$28.2K	0.09%	161
2020 Q1	$338K	Sell	4,433 -465	-9%	-$39.6K	0.09%	168
2019 Q4	$434K	Sell	4,898 -167	-3%	-$13.9K	0.09%	189
2019 Q3	$384K	Buy	5,065 +211	+4%	+$14.5K	0.08%	191
2019 Q2	$353K	Sell	4,854 -320	-6%	-$25.2K	0.08%	195
2019 Q1	$417K	Buy	5,174 +976	+23%	+$79.8K	0.12%	161
2018 Q4	$387K	Sell	4,198 -80	-2%	-$7.04K	0.14%	139
2018 Q3	$405K	Sell	4,278 -1	-0%	-$95	0.13%	158
2018 Q2	$396K	Sell	4,279 -587	-12%	-$57.3K	0.14%	157
2018 Q1	$461K	Buy	4,866 +83	+2%	+$9.12K	0.14%	167
2017 Q4	$463K	Sell	4,783 -7,850	-62%	-$740K	0.14%	164
2017 Q3	$1.12M	Buy	12,633 +217	+2%	+$16.5K	0.27%	106
2017 Q2	$900K	Sell	12,416 -955	-7%	-$64.2K	0.23%	120
2017 Q1	$871K	Buy	13,371 +1,808	+16%	+$114K	0.24%	117
2016 Q4	$724K	Buy	11,563 +816	+8%	+$49.8K	0.22%	127
2016 Q3	$678K	Sell	10,747 -370	-3%	-$24K	0.2%	128
2016 Q2	$688	Sell	11,117 -1,707	-13%	-$104K	0.08%	118
2016 Q1	$733K	Buy	12,824 +1,309	+11%	+$73K	0.28%	94
2015 Q4	$682K	Buy	11,515 +5	+0%	+$288	0.26%	101
2015 Q3	$626K	Buy	11,510 +1,790	+18%	+$117K	0.26%	111
2015 Q2	$653	Buy	+9,720	New	+$635K	0.18%	113

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

First Heartland Consultants's ABBV Position: Q2 2026 in Review

First Heartland Consultants increased its AbbVie (ABBV) stake by 5.5% in Q2 2026, buying an estimated $42.4K and bringing the position to 3,768 shares worth $948K. The position accounts for 0.06% of the portfolio, ranked #227.

First Heartland Consultants first reported a position in ABBV in Q2 2015 and has held it in 45 quarters since. The position peaked at $2.87M in Q1 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

First Heartland Consultants held 3,768 shares of AbbVie worth $948K as of Q2 2026.
First Heartland Consultants bought 197 AbbVie shares in Q2 2026, an estimated $42.4K.
AbbVie made up 0.06% of First Heartland Consultants's portfolio in Q2 2026, its #227 holding.
First Heartland Consultants first reported a position in AbbVie in Q2 2015 and has held it in 45 quarters since.
First Heartland Consultants's AbbVie position peaked at $2.87M in Q1 2022.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Heartland Consultants's 13F filing for Q2 2026, filed 8 Jul 2026.